Terumo Corp. Hits Day High with 18.57% Surge Amid Market Decline

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, achieving a remarkable intraday high of JPY 2,280.50. The stock surged by 18.57% on May 18, 2026, contrasting sharply with the Japan Nikkei 225, which declined by 0.97% on the same day. Over the past week, Terumo Corp. has shown a robust performance, gaining 16.45%, while the Nikkei 225 fell by 2.57%. Despite this recent uptick, the stock has faced challenges over the longer term, with a one-year performance decline of 16.17%, significantly lagging behind the Nikkei 225's impressive 61.09% return. Financially, Terumo Corp. maintains a strong ability to service its debt, evidenced by a healthy EBIT to Interest ratio of 36.60. The company has also demonstrated long-term growth potential, with net sales increasing at an annual rate of 12.52%. However, it trades at a premium compared to its peers, reflected in a price-to-book ratio of 2.07. As the stock continues to navigate its market position, today's performance marks a notable moment in its ongoing journey.